These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 8270460

  • 1. Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiation.
    Stromberg J, Martinez A, Benson R, Garton G, Diokno A, Gonzalez J, Zincke H, Schray M, Edmundson G, Brabbins D.
    Int J Radiat Oncol Biol Phys; 1994 Jan 01; 28(1):67-75. PubMed ID: 8270460
    [Abstract] [Full Text] [Related]

  • 2. Pelvic lymphadenectomy and transperineal interstitial implantation of IR 192 combined with external beam radiotherapy for bulky stage C prostatic carcinoma.
    Brindle JS, Martinez A, Schray M, Edmundson G, Benson RC, Zincke H, Diokno A, Gonzalez J.
    Int J Radiat Oncol Biol Phys; 1989 Nov 01; 17(5):1063-6. PubMed ID: 2808040
    [Abstract] [Full Text] [Related]

  • 3. Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
    Budrukkar AN, Shrivastava SK, Jalali R, Agarwal JP, Deshpande DD, Nehru RM, Dinshaw KA.
    Strahlenther Onkol; 2001 Oct 01; 177(10):517-24. PubMed ID: 11680016
    [Abstract] [Full Text] [Related]

  • 4. Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: treatment description and preliminary results of a phase I/II clinical trial.
    Stromberg J, Martinez A, Gonzalez J, Edmundson G, Ohanian N, Vicini F, Hollander J, Gustafson G, Spencer W, Yan Di.
    Int J Radiat Oncol Biol Phys; 1995 Aug 30; 33(1):161-71. PubMed ID: 7543891
    [Abstract] [Full Text] [Related]

  • 5. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
    Momma T, Saito S, Toya K, Yorozu A, Dokiya T, Murai M.
    Int J Urol; 2006 Mar 30; 13(3):218-23. PubMed ID: 16643612
    [Abstract] [Full Text] [Related]

  • 6. High-dose rate interstitial with external beam irradiation for localized prostate cancer--results of a prospective trial.
    Dinges S, Deger S, Koswig S, Boehmer D, Schnorr D, Wiegel T, Loening SA, Dietel M, Hinkelbein W, Budach V.
    Radiother Oncol; 1998 Aug 30; 48(2):197-202. PubMed ID: 9783892
    [Abstract] [Full Text] [Related]

  • 7. Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment.
    Stromberg JS, Martinez AA, Horwitz EM, Gustafson GS, Gonzalez JA, Spencer WF, Brabbins DS, Dmuchowski CF, Hollander JB, Vicini FA.
    Cancer J Sci Am; 1997 Aug 30; 3(6):346-52. PubMed ID: 9403047
    [Abstract] [Full Text] [Related]

  • 8. Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.
    Martinez AA, Kestin LL, Stromberg JS, Gonzalez JA, Wallace M, Gustafson GS, Edmundson GK, Spencer W, Vicini FA.
    Int J Radiat Oncol Biol Phys; 2000 May 01; 47(2):343-52. PubMed ID: 10802358
    [Abstract] [Full Text] [Related]

  • 9. Long-term results of treatment for prostate carcinoma by staging pelvic lymph node dissection and definitive irradiation using low-dose rate temporary iridium-192 interstitial implant and external beam radiotherapy.
    Puthawala AA, Syed AM, Austin PA, Cherlow JM, Perley JM, Shanberg AM, Sawyer DE, Ingram JE, Baghdassarian R, Wachs BH, Perley JE, Londrc A, Espinoza-Ferrel T.
    Cancer; 2001 Oct 15; 92(8):2084-94. PubMed ID: 11596024
    [Abstract] [Full Text] [Related]

  • 10. Prostate brachytherapy: treatment strategies.
    Stone NN, Stock RG.
    J Urol; 1999 Aug 15; 162(2):421-6. PubMed ID: 10411050
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
    Merrick GS, Butler WM, Galbreath RW, Lief JH, Adamovich E.
    Int J Radiat Oncol Biol Phys; 2002 Mar 01; 52(3):664-73. PubMed ID: 11849788
    [Abstract] [Full Text] [Related]

  • 13. Transperineal percutaneous iridium-192 interstitial template implant of the prostate: results and complications in 321 patients.
    Khan K, Thompson W, Bush S, Stidley C.
    Int J Radiat Oncol Biol Phys; 1992 Mar 01; 22(5):935-9. PubMed ID: 1555985
    [Abstract] [Full Text] [Related]

  • 14. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
    Grills IS, Martinez AA, Hollander M, Huang R, Goldman K, Chen PY, Gustafson GS.
    J Urol; 2004 Mar 01; 171(3):1098-104. PubMed ID: 14767279
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
    Jo Y, Hiratsuka J, Fujii T, Takenaka A, Fujisawa M.
    Urology; 2004 Sep 01; 64(3):556-60. PubMed ID: 15351592
    [Abstract] [Full Text] [Related]

  • 17. Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors.
    Martinez A, Gonzalez J, Spencer W, Gustafson G, Kestin L, Kearney D, Vicini FA.
    J Urol; 2003 Mar 01; 169(3):974-9; discussion 979-80. PubMed ID: 12576825
    [Abstract] [Full Text] [Related]

  • 18. Fractionated perineal high-dose-rate temporary brachytherapy combined with external beam radiation in the treatment of localized prostate cancer: is lymph node sampling necessary?
    Kovács G, Galalae R.
    Cancer Radiother; 2003 Apr 01; 7(2):100-6. PubMed ID: 12719039
    [Abstract] [Full Text] [Related]

  • 19. Favorable Preliminary Outcomes for Men With Low- and Intermediate-risk Prostate Cancer Treated With 19-Gy Single-fraction High-dose-rate Brachytherapy.
    Krauss DJ, Ye H, Martinez AA, Mitchell B, Sebastian E, Limbacher A, Gustafson GS.
    Int J Radiat Oncol Biol Phys; 2017 Jan 01; 97(1):98-106. PubMed ID: 27979460
    [Abstract] [Full Text] [Related]

  • 20. Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality.
    Kollmeier MA, Stock RG, Stone N.
    Int J Radiat Oncol Biol Phys; 2003 Nov 01; 57(3):645-53. PubMed ID: 14529768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.